ALLISON LEE: Open Payments
NPI 1225609712 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,213 in 57 payments from 12 companies in 2025. Trend: 2023 $1,753 · 2024 $832 · 2025 $1,213
Food & beverage: $1,213
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $347 |
| GlaxoSmithKline, LLC. | 16 | $342 |
| ABBVIE INC. | 9 | $172 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $68 |
| Dexcom, Inc. | 4 | $66 |
| Astellas Pharma US Inc | 3 | $64 |
| Exact Sciences Corporation | 3 | $43 |
| Inspire Medical Systems, Inc. | 1 | $39 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| Dynavax Technologies Corporation | 1 | $18 |
Products named: Ozempic, VRAYLAR, Wegovy, PENMENVY, AREXVY, SHINGRIX, JARDIANCE, Dexcom G6 Transmitter.
Industry payments across TX — which companies pay providers there.
